Drug Shortage Report for TWINRIX JUNIOR

Last updated on 2022-12-09 History
Report ID 168581
Drug Identification Number 02237548
Brand name TWINRIX JUNIOR
Common or Proper name Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN
Strength(s) 360UNIT 10MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1s
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-09-01
Estimated end date 2022-12-07
Actual end date 2022-12-08
Shortage status Resolved
Updated date 2022-12-09
Company comments Supply available for public programs. Supply unavailable in the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-12-09 English Compare
v9 2022-12-08 French Compare
v8 2022-12-08 English Compare
v7 2022-11-23 French Compare
v6 2022-11-23 English Compare
v5 2022-10-21 French Compare
v4 2022-10-21 English Compare
v3 2022-09-02 French Compare
v2 2022-09-02 French Compare
v1 2022-09-02 English Compare

Showing 1 to 10 of 10